These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 23349018

  • 1. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
    Díaz-García CV, Agudo-López A, Pérez C, López-Martín JA, Rodríguez-Peralto JL, de Castro J, Cortijo A, Martínez-Villanueva M, Iglesias L, García-Carbonero R, Fresno Vara JA, Gámez-Pozo A, Palacios J, Cortés-Funes H, Paz-Ares L, Agulló-Ortuño MT.
    Carcinogenesis; 2013 May; 34(5):1031-8. PubMed ID: 23349018
    [Abstract] [Full Text] [Related]

  • 2. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis.
    Tan X, Qin W, Zhang L, Hang J, Li B, Zhang C, Wan J, Zhou F, Shao K, Sun Y, Wu J, Zhang X, Qiu B, Li N, Shi S, Feng X, Zhao S, Wang Z, Zhao X, Chen Z, Mitchelson K, Cheng J, Guo Y, He J.
    Clin Cancer Res; 2011 Nov 01; 17(21):6802-11. PubMed ID: 21890451
    [Abstract] [Full Text] [Related]

  • 3. High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer.
    Czubak K, Lewandowska MA, Klonowska K, Roszkowski K, Kowalewski J, Figlerowicz M, Kozlowski P.
    Oncotarget; 2015 Sep 15; 6(27):23399-416. PubMed ID: 26156018
    [Abstract] [Full Text] [Related]

  • 4. The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma--differences in histological subtypes.
    Eide HA, Halvorsen AR, Bjaanæs MM, Piri H, Holm R, Solberg S, Jørgensen L, Brustugun OT, Kiserud CE, Helland Å.
    BMC Cancer; 2016 Feb 08; 16():71. PubMed ID: 26858029
    [Abstract] [Full Text] [Related]

  • 5. Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma.
    Hamamoto J, Soejima K, Yoda S, Naoki K, Nakayama S, Satomi R, Terai H, Ikemura S, Sato T, Yasuda H, Hayashi Y, Sakamoto M, Takebayashi T, Betsuyaku T.
    Mol Med Rep; 2013 Aug 08; 8(2):456-62. PubMed ID: 23759980
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y, Rosenfeld N, Chajut A, Cohen D, Aharonov R, Mansukhani M.
    J Clin Oncol; 2009 Apr 20; 27(12):2030-7. PubMed ID: 19273703
    [Abstract] [Full Text] [Related]

  • 7. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
    Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, Westra WH.
    Clin Cancer Res; 2010 Jan 15; 16(2):610-9. PubMed ID: 20068099
    [Abstract] [Full Text] [Related]

  • 8. Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients.
    Vincenzi B, Zoccoli A, Schiavon G, Iuliani M, Pantano F, Dell'aquila E, Ratta R, Muda AO, Perrone G, Brunelli C, Correale P, Riva E, Russo A, Loupakis F, Falcone A, Santini D, Tonini G.
    Eur J Cancer; 2013 Apr 15; 49(6):1501-8. PubMed ID: 23266047
    [Abstract] [Full Text] [Related]

  • 9. Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features.
    Capodanno A, Boldrini L, Proietti A, Alì G, Pelliccioni S, Niccoli C, D'Incecco A, Cappuzzo F, Chella A, Lucchi M, Mussi A, Fontanini G.
    Int J Oncol; 2013 Sep 15; 43(3):765-74. PubMed ID: 23820752
    [Abstract] [Full Text] [Related]

  • 10. Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling.
    Fassina A, Cappellesso R, Fassan M.
    Chest; 2011 Nov 15; 140(5):1305-1311. PubMed ID: 21622546
    [Abstract] [Full Text] [Related]

  • 11. Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer.
    Duncavage E, Goodgame B, Sezhiyan A, Govindan R, Pfeifer J.
    J Thorac Oncol; 2010 Nov 15; 5(11):1755-63. PubMed ID: 20975375
    [Abstract] [Full Text] [Related]

  • 12. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
    Inoue T, Iinuma H, Ogawa E, Inaba T, Fukushima R.
    Oncol Rep; 2012 Jun 15; 27(6):1759-64. PubMed ID: 22407237
    [Abstract] [Full Text] [Related]

  • 13. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y.
    Biomed Pharmacother; 2010 Jul 15; 64(6):399-408. PubMed ID: 20363096
    [Abstract] [Full Text] [Related]

  • 14. Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients.
    Jeong HC, Kim EK, Lee JH, Lee JM, Yoo HN, Kim JK.
    Mol Med Rep; 2011 Jul 15; 4(2):383-7. PubMed ID: 21468581
    [Abstract] [Full Text] [Related]

  • 15. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.
    Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C, Shen H.
    J Clin Oncol; 2010 Apr 01; 28(10):1721-6. PubMed ID: 20194856
    [Abstract] [Full Text] [Related]

  • 16. Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.
    Tafsiri E, Darbouy M, Shadmehr MB, Zagryazhskaya A, Alizadeh J, Karimipoor M.
    Tumour Biol; 2015 Mar 01; 36(3):1603-12. PubMed ID: 25384507
    [Abstract] [Full Text] [Related]

  • 17. Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer.
    Sand M, Gambichler T, Skrygan M, Sand D, Scola N, Altmeyer P, Bechara FG.
    Cancer Invest; 2010 Jul 01; 28(6):649-53. PubMed ID: 20210522
    [Abstract] [Full Text] [Related]

  • 18. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J, Liu H, Wang H, Sun Y.
    Pathol Res Pract; 2013 Aug 01; 209(8):490-4. PubMed ID: 23827213
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.
    Patnaik SK, Kannisto E, Knudsen S, Yendamuri S.
    Cancer Res; 2010 Jan 01; 70(1):36-45. PubMed ID: 20028859
    [Abstract] [Full Text] [Related]

  • 20. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L, Shan W, Zhang Y, Lv X, Li X, Wei C.
    Pathol Oncol Res; 2016 Jan 01; 22(1):161-7. PubMed ID: 26453197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.